Collectively, our results indicate that VCC-1 is a downstream regulator of OCT4 and is a promising biomarker and therapeutic target for lung cancer, emphasizing the critical roles of OCT4 and VCC-1 in cancer development. Here, POU5F1 is linked to lung carcinoma.